胰高血糖素样肽-1-话题@MedSci

#胰高血糖素样肽-1#

23篇内容 | 2055人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2214031, encodeId=87a7221403113, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a> <a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果, objectType=article, longId=833714, objectId=4179833e1497, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720492866217_92910.png, objectUrl=/article/show_article.do?id=4179833e1497, replyNumber=0, likeNumber=56, createdTime=2024-07-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4179833e1497, moduleTitle=Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4179833e1497)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2118789, encodeId=3d6f2118e8947, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a> （<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>）为基础的药物，包括<a href='/topic/show?id=bb0e8081b2' target=_blank style='color:#2F92EE;'>#GLP-1受体激动剂#</a>（GLP-1RA）和<a href='/topic/show?id=788a24043af' target=_blank style='color:#2F92EE;'>#二肽基肽酶-4抑制剂#</a> （<a href='/topic/show?id=03d2622088' target=_blank style='color:#2F92EE;'>#DPP4i#</a>），是用于治疗<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a>的<a href='/topic/show?id=98e610556057' target=_blank style='color:#2F92EE;'>#肠促胰素类药物#</a>。除了肠促胰素效应外，GLP-1为基础的药物还具有<a href='/topic/show?id=98c0553894c' target=_blank style='color:#2F92EE;'>#抗炎#</a>作用。然而，既往一项研究报告使用DPP4i会增加<a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a>（IBD）风险。, objectTitle=ECCO 2023 | GLP-1为基础的药物与炎症性肠病风险：来自国家队列研究的真实世界证据, objectType=article, longId=762356, objectId=7d8be62356b3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230111/361cfc26c42642a891ede2db100a3ffa.jpg, objectUrl=/article/show_article.do?id=7d8be62356b3, replyNumber=0, likeNumber=175, createdTime=2023-03-11, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7d8be62356b3, moduleTitle=ECCO 2023 | GLP-1为基础的药物与炎症性肠病风险：来自国家队列研究的真实世界证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d8be62356b3)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1694270, encodeId=87f916942e075, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes Obes Metab：双胰高血糖素样肽-1/胰高血糖素受体激动剂SAR425899可明显改善T2D患者的餐后糖代谢, objectType=article, longId=209702, objectId=ff5f209e02a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff5f209e02a5, replyNumber=0, likeNumber=99, createdTime=2022-01-14, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff5f209e02a5, moduleTitle=Diabetes Obes Metab：双胰高血糖素样肽-1/胰高血糖素受体激动剂SAR425899可明显改善T2D患者的餐后糖代谢, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff5f209e02a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694266, encodeId=b4901694266ad, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病, objectType=article, longId=158881, objectId=95b715888182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b715888182, replyNumber=0, likeNumber=74, createdTime=2019-02-25, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b715888182, moduleTitle=人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95b715888182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694268, encodeId=e3f3169426834, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=AP&T： DPP-4抑制剂维达列汀可抑制胃调节并增加胰高血糖素样肽-1血浆水平, objectType=article, longId=162307, objectId=fc3b16230e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3b16230e8f, replyNumber=0, likeNumber=74, createdTime=2019-12-18, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3b16230e8f, moduleTitle=AP&T： DPP-4抑制剂维达列汀可抑制胃调节并增加胰高血糖素样肽-1血浆水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc3b16230e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694269, encodeId=a35d169426928, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病, objectType=article, longId=176930, objectId=78571e6930a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78571e6930a3, replyNumber=0, likeNumber=85, createdTime=2020-05-07, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78571e6930a3, moduleTitle=2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78571e6930a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694265, encodeId=445616942657a, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响, objectType=article, longId=150287, objectId=f97e15028ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f97e15028ec4, replyNumber=0, likeNumber=69, createdTime=2018-11-01, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f97e15028ec4, moduleTitle=JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f97e15028ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694267, encodeId=3d70169426e82, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？, objectType=article, longId=159916, objectId=fef6159916b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef6159916b0, replyNumber=0, likeNumber=85, createdTime=2020-01-04, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef6159916b0, moduleTitle=Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef6159916b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694264, encodeId=a152169426418, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Lancet：胖子的福音！新型胰高血糖素样肽-1类似物索马鲁肽可长期用于减肥, objectType=article, longId=146858, objectId=50d3146858ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50d3146858ed, replyNumber=0, likeNumber=85, createdTime=2018-10-16, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50d3146858ed, moduleTitle=Lancet：胖子的福音！新型胰高血糖素样肽-1类似物索马鲁肽可长期用于减肥, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50d3146858ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694263, encodeId=715b1694263aa, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetologia：新型胰高血糖素样肽-1受体抗体的开发和特征, objectType=article, longId=135132, objectId=3cc61351326d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc61351326d, replyNumber=0, likeNumber=71, createdTime=2019-02-25, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc61351326d, moduleTitle=Diabetologia：新型胰高血糖素样肽-1受体抗体的开发和特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cc61351326d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694261, encodeId=6e74169426179, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetologia：为什么在小鼠中测量胰高血糖素样肽-1是如此困难？, objectType=article, longId=117897, objectId=426f11e897ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=426f11e897ed, replyNumber=0, likeNumber=73, createdTime=2017-10-28, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=426f11e897ed, moduleTitle=Diabetologia：为什么在小鼠中测量胰高血糖素样肽-1是如此困难？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=426f11e897ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694259, encodeId=47c0169425991, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes：胰高血糖素样肽-1受体激活可增加心输出量和心脏效率！, objectType=article, longId=98262, objectId=070698262f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=070698262f9, replyNumber=0, likeNumber=78, createdTime=2017-06-17, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=070698262f9, moduleTitle=Diabetes：胰高血糖素样肽-1受体激活可增加心输出量和心脏效率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=070698262f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694262, encodeId=1f5516942620d, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, objectType=article, longId=124605, objectId=82221246057a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82221246057a, replyNumber=0, likeNumber=54, createdTime=2018-09-27, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82221246057a, moduleTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82221246057a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694258, encodeId=631a169425882, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes：胰高血糖素样肽-1通过增加自噬流和恢复溶酶体功能对胰岛β细胞发挥保护作用！, objectType=article, longId=92341, objectId=fc2592341f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2592341f0, replyNumber=0, likeNumber=79, createdTime=2017-08-07, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2592341f0, moduleTitle=Diabetes：胰高血糖素样肽-1通过增加自噬流和恢复溶酶体功能对胰岛β细胞发挥保护作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc2592341f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694260, encodeId=75fe16942609e, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, objectType=article, longId=103787, objectId=d625103e8766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d625103e8766, replyNumber=0, likeNumber=80, createdTime=2017-12-11, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d625103e8766, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d625103e8766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694256, encodeId=86251694256eb, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Heart：治疗2型糖尿病选择胰岛素还是胰高血糖素样肽-1类似物？, objectType=article, longId=78369, objectId=e187e83694c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e187e83694c, replyNumber=0, likeNumber=79, createdTime=2017-06-05, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e187e83694c, moduleTitle=Heart：治疗2型糖尿病选择胰岛素还是胰高血糖素样肽-1类似物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e187e83694c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694257, encodeId=0e1b169425eb1, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=BMJ：胰高血糖素样肽-1类似物不会增加乳腺癌风险, objectType=article, longId=80613, objectId=a3cc8061374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3cc8061374, replyNumber=0, likeNumber=78, createdTime=2017-07-04, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3cc8061374, moduleTitle=BMJ：胰高血糖素样肽-1类似物不会增加乳腺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3cc8061374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694255, encodeId=58fa16942554a, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=胰高血糖素样肽-1受体激动剂研究进展, objectType=article, longId=73867, objectId=f2e1e386705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2e1e386705, replyNumber=0, likeNumber=104, createdTime=2017-07-12, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2e1e386705, moduleTitle=胰高血糖素样肽-1受体激动剂研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2e1e386705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694254, encodeId=f5a616942549b, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, objectType=article, longId=61856, objectId=db2c6185660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db2c6185660, replyNumber=0, likeNumber=88, createdTime=2016-07-29, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db2c6185660, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db2c6185660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694253, encodeId=8c2416942533d, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a>, objectTitle=Hypertension：胰高血糖素样肽-1与动态血压呈线性相关, objectType=article, longId=43848, objectId=e2a24384872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a24384872, replyNumber=0, likeNumber=79, createdTime=2015-04-08, rootId=0, userName=liuquanmn, userId=9c5929589014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a24384872, moduleTitle=Hypertension：胰高血糖素样肽-1与动态血压呈线性相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a24384872)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胰高血糖素样肽-1

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1# #抗精神病药物# #胰高血糖素样肽-1受体激动剂#

Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果

2024-07-09发表于上海

showtest (审核中...)

前往app查看评论内容

全文收起 #胰高血糖素样肽-1# （#GLP-1#）为基础的药物，包括#GLP-1受体激动剂#（GLP-1RA）和#二肽基肽酶-4抑制剂# （#DPP4i#），是用于治疗#2型糖尿病#的#肠促胰素类药物#。除了肠促胰素效应外，GLP-1为基础的药物还具有#抗炎#作用。然而，既往一项研究报告使用DPP4i会增加#炎症性肠病#（IBD）风险。

ECCO 2023 | GLP-1为基础的药物与炎症性肠病风险：来自国家队列研究的真实世界证据

2023-03-11发表于上海

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes Obes Metab：双胰高血糖素样肽-1/胰高血糖素受体激动剂SAR425899可明显改善T2D患者的餐后糖代谢

2022-01-14

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

人胰高血糖素样肽-1类似物Ozempic在英国上市用于治疗II型糖尿病

2019-02-25

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

AP&T： DPP-4抑制剂维达列汀可抑制胃调节并增加胰高血糖素样肽-1血浆水平

2019-12-18

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病

2020-05-07

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响

2018-11-01

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？

2020-01-04

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Lancet：胖子的福音！新型胰高血糖素样肽-1类似物索马鲁肽可长期用于减肥

2018-10-16

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetologia：新型胰高血糖素样肽-1受体抗体的开发和特征

2019-02-25

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetologia：为什么在小鼠中测量胰高血糖素样肽-1是如此困难？

2017-10-28

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes：胰高血糖素样肽-1受体激活可增加心输出量和心脏效率！

2017-06-17

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病

2018-09-27

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes：胰高血糖素样肽-1通过增加自噬流和恢复溶酶体功能对胰岛β细胞发挥保护作用！

2017-08-07

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性

2017-12-11

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Heart：治疗2型糖尿病选择胰岛素还是胰高血糖素样肽-1类似物？

2017-06-05

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

BMJ：胰高血糖素样肽-1类似物不会增加乳腺癌风险

2017-07-04

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

胰高血糖素样肽-1受体激动剂研究进展

2017-07-12

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析

2016-07-29

liuquanmn (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1#

Hypertension：胰高血糖素样肽-1与动态血压呈线性相关

2015-04-08

科室
- - 订阅+
  - 更多科室
工具
服务